article thumbnail

Genemod Raises $4.5M to Expand Central Research Platform for Biopharma Companies

HIT Consultant

Genemod digitizes data capture and workflows, so scientists can collaborate easily across an organization to accelerate life sciences R&D. The intuitive interface allows users to easily visualize their data and track progress and updates – including what changes are made by whom.

article thumbnail

Sanofi & Flatiron Health Partner to Redesign Clinical Trial Experience for Sponsors

HIT Consultant

What You Should Know: Flatiron Health announced a new partnership today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

HIT Consultant

The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data acquisition as well as increase its discovery activities via pharma partnerships. . – The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund.

article thumbnail

Clinical Trial Data Strategy: Shifting to Innovative Data Collection and Flow While Reducing Burden On Your Sites

HIT Consultant

Their insights early on can help teams involved in data collection, cleaning and analysis by making sure the data is adequate for their activities while adhering to quality standards.

article thumbnail

UBC Partners with Seqster to Advance Patient-Centric Clinical Trials

HIT Consultant

Seqster’s turnkey white label solution facilitates the rapid move to a fully decentralized approach with automated data acquisition and abstraction. Traditional site-based clinical studies rely on manual data capture methods and in-person attendance of study participants. Why It Matters.